4173.TWO Arich Enterprise Co Ltd
- Market cap
- TWD 1.33B
- P/E
- 22.3x
- P/B
- 0.70x
- ROE
- 3.3%
- Dividend yield
- 6.66%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 4173.TWO undervalued?
Graham number4173.TWO trades 16.4% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Arich Enterprise Co Ltd fundamental analysis
No fundamental analysis for Arich Enterprise Co Ltd yet.
Arich Enterprise Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Arich Enterprise Co Ltd
Arich Enterprise Co., Ltd. engages in the marketing, promotion, and distribution of pharmaceuticals in Taiwan. It offers sales promotion for pharmaceutical products; warehousing and logistics, and processing services. The company provides distribution and logistics services, including assists manufacturers with bidding processes; inventory management, order processing, invoicing, goods delivery, collection, customer complaint handling, and provides integrated pharmaceutical …
Full company profileArich Enterprise Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Arich Enterprise Co Ltd annual financial statements (TWD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 1.20B | 1.30B | 1.11B | 1.25B | 946M | 1.02B | 1.14B | 1.30B | 1.55B | 1.58B |
| Gross Profit | 161M | 221M | 200M | 217M | 208M | 207M | 233M | 253M | 311M | 305M |
| Operating Income | 2.74M | 47.0M | 61.6M | 65.4M | 78.7M | 84.6M | 99.0M | 95.1M | 104M | 80.0M |
| EBITDA | 24.1M | 67.7M | 119M | 100M | 120M | 127M | 149M | 164M | 184M | 169M |
| Net Income | 5.19M | 50.3M | 60.6M | 47.2M | 55.3M | 62.6M | 76.5M | 93.9M | 86.8M | 62.0M |
| EPS | 0.11 | 1.02 | 1.23 | 0.72 | 0.74 | 0.84 | 1.02 | 1.26 | 1.16 | 0.83 |
| Balance Sheet | ||||||||||
| Total Assets | 5.33B | 4.71B | 3.76B | 3.95B | 4.49B | 4.94B | 5.62B | 7.10B | 5.26B | 5.18B |
| Total Liabilities | 4.28B | 3.50B | 2.50B | 2.17B | 2.67B | 3.06B | 3.60B | 5.18B | 3.25B | 3.29B |
| Shareholders' Equity | 1.05B | 1.21B | 1.26B | 1.78B | 1.82B | 1.88B | 2.02B | 1.92B | 2.01B | 1.89B |
| Cash & Short-term Investments | 298M | 80.2M | 582M | 573M | 610M | 707M | 577M | 2.23B | 711M | 726M |
| Total Debt | - | - | - | 284M | 165M | 64.5M | 329M | - | - | - |
| Cash Flow | ||||||||||
| Operating Cash Flow | -627M | -233M | 564M | 560M | 336M | 139M | -274M | 2.15B | -1.90B | 896M |
| Capital Expenditure | 1.41M | 304K | 3.08M | 5.48M | 13.1M | 22.4M | 28.9M | 6.36M | 7.36M | 37.6M |
| Free Cash Flow | -630M | -251M | 548M | 554M | 323M | 117M | -303M | 2.14B | -1.91B | 858M |
| Ratios | ||||||||||
| ROE | 0.5% | 4.2% | 4.8% | 2.7% | 3.0% | 3.3% | 3.8% | 4.9% | 4.3% | 3.3% |
| ROA | 0.1% | 1.1% | 1.6% | 1.2% | 1.2% | 1.3% | 1.4% | 1.3% | 1.7% | 1.2% |
| Net Profit Margin | 0.4% | 3.9% | 5.5% | 3.8% | 5.8% | 6.2% | 6.7% | 7.2% | 5.6% | 3.9% |
| Debt to Equity | - | - | - | 0.16x | 0.09x | 0.03x | 0.16x | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Arich Enterprise Co Ltd dividends
- Dividend yield
- 6.66%
- Forward dividend
- 1.04 TWD
- Payout ratio
- 102.1%
- Ex-dividend date
- Apr 16, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | TWD 88.6M | 1.19 | 102.1% |
| 2024 | TWD 68.6M | 0.92 | 73.1% |
| 2023 | TWD 48.5M | 0.65 | 63.3% |
| 2022 | TWD 37.3M | 0.50 | 59.5% |
| 2021 | TWD 41.8M | 0.56 | 75.5% |
| 2020 | TWD 44.6M | 0.68 | 94.3% |
| 2019 | TWD 46.3M | 0.94 | 76.4% |
| 2018 | TWD 13.4M | 0.27 | 26.6% |
| 2017 | TWD 23.9M | 0.48 | 460.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Arich Enterprise Co Ltd
- Insiders 45.09%
- Institutions 0.00%
- Public & others 54.91%
- Shares outstanding 74.6M
- Free float 44.7M
Arich Enterprise Co Ltd company profile
- Company name
- Arich Enterprise Co Ltd
- Ticker
- 4173.TWO
- ISIN
- TW0004173000
- Exchange
- Taiwan OTC Exchange
- Sector
- Healthcare
- Industry
- Consumer Staples Distribution & Retail
- Fiscal year end
- December
- Address
- No.880, Zhongzheng Road, New Taipei City, Taiwan, 235601
- Phone
- 886 2 8227 7999
- Website
- arich.com.tw
About Arich Enterprise Co Ltd
Arich Enterprise Co., Ltd. engages in the marketing, promotion, and distribution of pharmaceuticals in Taiwan. It offers sales promotion for pharmaceutical products; warehousing and logistics, and processing services. The company provides distribution and logistics services, including assists manufacturers with bidding processes; inventory management, order processing, invoicing, goods delivery, collection, customer complaint handling, and provides integrated pharmaceutical distribution services. In addition, it offers activities, such as hospital tender and bidding; pharmaceutical pricing negotiations; cold chain, clinical trial drug, and controlled drugs management; information, and financial flow. Arich Enterprise Co., Ltd. was founded in 1969 and is based in New Taipei City, Taiwan.
Arich Enterprise Co Ltd management
2- Hung Wen-ChuanGeneral Manager
- Yi Wen LinCFO & Accounting Supervisor